Longboard Pharmaceuticals Inc (LBPH)
20.66
+0.15
(+0.73%)
USD |
NASDAQ |
May 17, 16:00
20.66
0.00 (0.00%)
After-Hours: 20:00
Longboard Pharmaceuticals Total Liabilities (Quarterly): 13.96M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 13.96M |
| December 31, 2023 | 9.774M |
| September 30, 2023 | 6.82M |
| June 30, 2023 | 8.115M |
| March 31, 2023 | 7.551M |
| December 31, 2022 | 9.146M |
| September 30, 2022 | 8.622M |
| Date | Value |
|---|---|
| June 30, 2022 | 7.544M |
| March 31, 2022 | 6.778M |
| December 31, 2021 | 5.629M |
| September 30, 2021 | 4.296M |
| June 30, 2021 | 3.273M |
| March 31, 2021 | 4.044M |
| December 31, 2020 | 58.93M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
3.273M
Minimum
Jun 2021
58.93M
Maximum
Dec 2020
11.03M
Average
7.548M
Median
Total Liabilities (Quarterly) Benchmarks
| CEL-SCI Corp | 15.74M |
| AIM ImmunoTech Inc | 9.147M |
| IGC Pharma Inc | 2.206M |
| NovaBay Pharmaceuticals Inc | 5.197M |
| Protalix BioTherapeutics Inc | 60.04M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 327.66M |
| Shareholders Equity (Quarterly) | 313.71M |